AAAAAA

   
Results: 1-25 | 26-45 |
Results: 26-45/45
Evaluation of the proliferative index as a prognostic factor in diffuse large cell lymphoma: Correlation with the International Index
Authors: Ansell, SM Kurtin, PJ Stenson, M Habermann, TM Greipp, PR Therneau, TM Witzig, TE
Citation: Sm. Ansell et al., Evaluation of the proliferative index as a prognostic factor in diffuse large cell lymphoma: Correlation with the International Index, LEUK LYMPH, 34(5-6), 1999, pp. 529-537
Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma
Authors: Rajkumar, SV Fonseca, R Lacy, MQ Witzig, TE Therneau, TM Kyle, RA Litzow, MR Gertz, MA Greipp, PR
Citation: Sv. Rajkumar et al., Plasmablastic morphology is an independent predictor of poor survival after autologous stem-cell transplantation for multiple myeloma, J CL ONCOL, 17(5), 1999, pp. 1551-1557
Hepatic retransplantation in cholestatic liver disease: Impact of the interval to retransplantation on survival and resource utilization
Authors: Kim, WR Wiesner, RH Poterucha, JJ Therneau, TM Malinchoc, M Benson, JT Crippin, JS Klintmalm, GBG Rakela, J Starzl, TE Krom, RAF Evans, RW Dickson, ER
Citation: Wr. Kim et al., Hepatic retransplantation in cholestatic liver disease: Impact of the interval to retransplantation on survival and resource utilization, HEPATOLOGY, 30(2), 1999, pp. 395-400
The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis
Authors: Kim, WR Poterucha, JJ Wiesner, RH LaRusso, NF Lindor, KD Petz, J Therneau, TM Malinchoc, M Dickson, ER
Citation: Wr. Kim et al., The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis, HEPATOLOGY, 29(6), 1999, pp. 1643-1648
Incidence of cancer in primary biliary cirrhosis: The Mayo experience
Authors: Nijhawan, PK Therneau, TM Dickson, ER Boynton, J Lindor, KD
Citation: Pk. Nijhawan et al., Incidence of cancer in primary biliary cirrhosis: The Mayo experience, HEPATOLOGY, 29(5), 1999, pp. 1396-1398
Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis
Authors: Angulo, P Batts, KP Therneau, TM Jorgensen, RA Dickson, ER Lindor, KD
Citation: P. Angulo et al., Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis, HEPATOLOGY, 29(3), 1999, pp. 644-647
Quality of life before and after liver transplantation for cholestatic liver disease
Authors: Gross, CR Malinchoc, M Kim, WR Evans, RW Wiesner, RH Petz, JL Crippin, JS Klintmalm, GB Levy, MF Ricci, P Therneau, TM Dickson, ER
Citation: Cr. Gross et al., Quality of life before and after liver transplantation for cholestatic liver disease, HEPATOLOGY, 29(2), 1999, pp. 356-364
Timing of transplantation for primary biliary cirrhosis - Reply
Authors: Kim, WR Therneau, TM Dickson, ER
Citation: Wr. Kim et al., Timing of transplantation for primary biliary cirrhosis - Reply, HEPATOLOGY, 29(2), 1999, pp. 609-610
Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma
Authors: Rajkumar, SV Fonseca, R Lacy, MQ Witzig, TE Lust, JA Greipp, PR Therneau, TM Kyle, RA Litzow, MR Gertz, MA
Citation: Sv. Rajkumar et al., Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma, BONE MAR TR, 24(5), 1999, pp. 497-503
Beta(2)-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma
Authors: Rajkumar, SV Fonseca, R Lacy, MQ Witzig, TE Lust, JA Greipp, PR Therneau, TM Kyle, RA Litzow, MR Gertz, MA
Citation: Sv. Rajkumar et al., Beta(2)-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myeloma, BONE MAR TR, 23(12), 1999, pp. 1261-1266
Autologous stem cell transplantation for relapsed and primary refractory myeloma
Authors: Rajkumar, SV Fonseca, R Lacy, MQ Witzig, TE Lust, JA Greipp, PR Therneau, TM Kyle, RA Litzow, MR Gertz, MA
Citation: Sv. Rajkumar et al., Autologous stem cell transplantation for relapsed and primary refractory myeloma, BONE MAR TR, 23(12), 1999, pp. 1267-1272
Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial
Authors: Angulo, P Dickson, ER Therneau, TM Jorgensen, RA Smith, C DeSotel, CK Lange, SM Anderson, ML Mahoney, DW Lindor, KD
Citation: P. Angulo et al., Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial, J HEPATOL, 30(5), 1999, pp. 830-835
Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma
Authors: Rajkumar, SV Fonseca, R Dewald, GW Therneau, TM Lacy, MQ Kyle, RA Greipp, PR Gertz, MA
Citation: Sv. Rajkumar et al., Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma, CANC GENET, 113(1), 1999, pp. 73-77
Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid
Authors: Angulo, P Lindor, KD Therneau, TM Jorgensen, RA Malinchoc, M Kamath, PS Dickson, ER
Citation: P. Angulo et al., Utilization of the Mayo risk score in patients with primary biliary cirrhosis receiving ursodeoxycholic acid, LIVER, 19(2), 1999, pp. 115-121
Population-based screening for postpartum depression
Authors: Georgiopoulos, AM Bryan, TL Yawn, BP Houston, MS Rummans, TA Therneau, TM
Citation: Am. Georgiopoulos et al., Population-based screening for postpartum depression, OBSTET GYN, 93(5), 1999, pp. 653-657
Evaluation of consultation-based rehabilitation for hospitalized cancer patients with functional impairment
Authors: Sabers, SR Kokal, JE Girardi, JC Philpott, CLF Basford, JR Therneau, TM Schmidt, KD Gamble, GL
Citation: Sr. Sabers et al., Evaluation of consultation-based rehabilitation for hospitalized cancer patients with functional impairment, MAYO CLIN P, 74(9), 1999, pp. 855-861
Long-term survival (10 years or more) in 30 patients with primary amyloidosis
Authors: Kyle, RA Gertz, MA Greipp, PR Witzig, TE Lust, JA Lacy, MQ Therneau, TM
Citation: Ra. Kyle et al., Long-term survival (10 years or more) in 30 patients with primary amyloidosis, BLOOD, 93(3), 1999, pp. 1062-1066
Time course of histological progression in primary sclerosing cholangitis
Authors: Angulo, P Larson, DR Therneau, TM LaRusso, NF Batts, KP Lindor, KD
Citation: P. Angulo et al., Time course of histological progression in primary sclerosing cholangitis, AM J GASTRO, 94(11), 1999, pp. 3310-3313
Clinical significance of TT virus infection in patients with chronic hepatitis C
Authors: Zein, NN Arslan, M Li, HJ Charlton, MR Gross, JB Poterucha, JJ Therneau, TM Kolbert, CP Persing, DH
Citation: Nn. Zein et al., Clinical significance of TT virus infection in patients with chronic hepatitis C, AM J GASTRO, 94(10), 1999, pp. 3020-3027
Chromosomal abnormalities in systemic amyloidosis
Authors: Fonseca, R Ahmann, GJ Jalal, SM Dewald, GW Larson, DR Therneau, TM Gertz, MA Kyle, RA Greipp, PR
Citation: R. Fonseca et al., Chromosomal abnormalities in systemic amyloidosis, BR J HAEM, 103(3), 1998, pp. 704-710
Risultati: 1-25 | 26-45 |